|
Κυριακή 7 Φεβρουαρίου 2021
[New approval: Atezolizumab and bevacizumab for first line of unresecable hepatocellular carcinoma].
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Academic Emergency Medicine, EarlyView. from Emergency Medicine via xlomafota13 on Inoreader https://ift.tt/2JxJINK
-
This feed no longer exists. Cambridge Journals Online and Cambridge Books Online have been replaced by Cambridge University Press’s new acad...
-
Objectives: Opioids and benzodiazepines are commonly used to provide analgesia and sedation for critically ill children with cardiac disease...
-
Objective: Inotropic and vasopressor drugs are routinely used in critically ill patients to maintain adequate blood pressure and cardiac ou...
-
Academic Emergency Medicine, EarlyView. from Emergency Medicine via xlomafota13 on Inoreader https://ift.tt/2Lq7OXW
-
Abstract This paper proposes a novel system to protect the fingerprint database based on compressed binary fingerprint images. In this sys...
-
Abstract Background and Significance Adverse drug events (ADEs) occur in approximately 2–5% of hospitalized patients, often resulting in...
-
Steve Whitehead, host of Remember 2 Things, talks about why you should read your glucometer manual to get an accurate sample and how you can...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου